loadpatents
Patent applications and USPTO patent grants for Friedlander; Arthur M..The latest application filed is for "pegylated capsule-degrading enzyme for the treatment of anthrax".
Patent | Date |
---|---|
Pegylated Capsule-Degrading Enzyme for the Treatment of Anthrax App 20220233703 - Legler; Patricia M. ;   et al. | 2022-07-28 |
Treatment methods using an F1-V plague vaccine Grant 8,795,677 - Heath , et al. August 5, 2 | 2014-08-05 |
Recombinant F1-V plague vaccine Grant 8,647,633 - Heath , et al. February 11, 2 | 2014-02-11 |
Recombinant F1-V Plague Vaccine App 20120164156 - Heath; David G. ;   et al. | 2012-06-28 |
Recombinant poly-glutamic acid depolymerases App 20100226906 - Friedlander; Arthur M. ;   et al. | 2010-09-09 |
Recombinant F1-V Plague Vaccine App 20090022756 - Heath; David G. ;   et al. | 2009-01-22 |
Recombinant F1-v Plague Vaccine App 20070043215 - HEATH; DAVID G. ;   et al. | 2007-02-22 |
Method of making a vaccine for anthrax Grant 6,387,665 - Ivins , et al. May 14, 2 | 2002-05-14 |
Method Of Making A Vaccine App 20020034512 - Ivins, Bruce ;   et al. | 2002-03-21 |
Asporogenic B anthracis expression system Grant 6,316,006 - Worsham , et al. November 13, 2 | 2001-11-13 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.